Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) EPS (Basic) (2016 - 2025)

Avanos Medical (AVNS) has disclosed EPS (Basic) for 13 consecutive years, with -$0.02 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 99.77% to -$0.02 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.57 through Dec 2025, up 81.72% year-over-year, with the annual reading at -$1.57 for FY2025, 81.59% up from the prior year.
  • EPS (Basic) hit -$0.02 in Q4 2025 for Avanos Medical, up from -$0.03 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.8 in Q2 2021 to a low of -$8.76 in Q4 2024.
  • Historically, EPS (Basic) has averaged -$0.54 across 5 years, with a median of $0.02 in 2024.
  • Biggest five-year swings in EPS (Basic): skyrocketed 1433.33% in 2021 and later plummeted 4250.0% in 2025.
  • Year by year, EPS (Basic) stood at $0.24 in 2021, then decreased by 12.5% to $0.21 in 2022, then rose by 9.52% to $0.23 in 2023, then plummeted by 3908.7% to -$8.76 in 2024, then soared by 99.77% to -$0.02 in 2025.
  • Business Quant data shows EPS (Basic) for AVNS at -$0.02 in Q4 2025, -$0.03 in Q3 2025, and -$1.66 in Q2 2025.